HomeNewsBusinessAir India takeover | Will focus on bringing down operational costs, says Tata Sons Chairman N Chandrasekaran
Trending Topics

Air India takeover | Will focus on bringing down operational costs, says Tata Sons Chairman N Chandrasekaran

"The strategic divestment transaction has been completed today with Government receiving a consideration of Rs 2,700 crore from Strategic Partner (M/s Talace Pvt Ltd, a wholly owned subsidiary of M/s Tata Sons Pvt Ltd)," the government said in a press release.

January 27, 2022 / 22:39 IST
Story continues below Advertisement
Air India pilots who worked with him remember J.R.D. as strict but always polite, and a stickler for values like on-time travel and high quality of service. (Image of JRD Tata tweeted by Ratan Tata)
Air India pilots who worked with him remember J.R.D. as strict but always polite, and a stickler for values like on-time travel and high quality of service. (Image of JRD Tata tweeted by Ratan Tata)

The divestment process of Air India was officially completed on January 27, after the central government handed over the management control and its shares in the airline to the Tata Group.

"The strategic divestment transaction has been completed today with Government receiving a consideration of Rs 2,700 crore from Strategic Partner (M/s Talace Pvt Ltd, a wholly-owned subsidiary of M/s Tata Sons Pvt Ltd)," the government said in a press release.

Story continues below Advertisement

Apart from the cash consideration, the Tata Group will also take over debt amounting to Rs 15,300 crore, the government said.

The transaction covers three entities – Air India, Air India Express, and AI SATS. Air India is India’s flag carrier and premier full-service airline. Air India Express is a low-cost carrier. AI SATS provides a comprehensive suite of ground handling and cargo handling services.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show